SIMILAR PATTERNS OF AMINO ACIDS FOR 4NJT_B_017B101_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1bou 4,5-DIOXYGENASE BETA
CHAIN


(Sphingomonas
paucimobilis)
PF02900
(LigB)
5 LEU B 133
ILE B 277
GLY B   7
PRO B  51
ILE B 136
None
0.96A 4njtA-1bouB:
undetectable
4njtA-1bouB:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ekq HYDROXYETHYLTHIAZOLE
KINASE


(Bacillus
subtilis)
PF02110
(HK)
5 LEU A 215
ALA A 119
VAL A 204
GLY A 122
ILE A 167
None
0.85A 4njtA-1ekqA:
undetectable
4njtA-1ekqA:
18.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1eqw CU,ZN SUPEROXIDE
DISMUTASE


(Salmonella
enterica)
PF00080
(Sod_Cu)
5 LEU A  28
ALA A  99
GLY A  84
PRO A  31
THR A  30
None
0.97A 4njtA-1eqwA:
undetectable
4njtA-1eqwA:
20.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ga8 GALACTOSYL
TRANSFERASE LGTC


(Neisseria
meningitidis)
PF01501
(Glyco_transf_8)
5 ASP A   2
VAL A   4
ILE A  93
GLY A  90
ILE A 169
None
0.78A 4njtA-1ga8A:
undetectable
4njtA-1ga8A:
13.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ga8 GALACTOSYL
TRANSFERASE LGTC


(Neisseria
meningitidis)
PF01501
(Glyco_transf_8)
5 LEU A 157
ASP A   2
VAL A   4
ILE A  93
GLY A  90
None
0.90A 4njtA-1ga8A:
undetectable
4njtA-1ga8A:
13.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gae D-GLYCERALDEHYDE-3-P
HOSPHATE
DEHYDROGENASE


(Escherichia
coli)
PF00044
(Gp_dh_N)
PF02800
(Gp_dh_C)
5 ALA O  19
VAL O   3
ILE O 325
ILE O  11
ILE O  27
None
None
None
NAD  O 336 (-3.9A)
None
0.89A 4njtA-1gaeO:
undetectable
4njtA-1gaeO:
15.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gq8 PECTINESTERASE

(Daucus carota)
PF01095
(Pectinesterase)
5 LEU A 167
VAL A 235
ILE A 240
GLY A 207
ILE A 201
None
0.93A 4njtA-1gq8A:
undetectable
4njtA-1gq8A:
13.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
PRO A  81
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.8A)
1.34A 4njtA-1hvcA:
13.7
4njtA-1hvcA:
43.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
ILE A  50
PRO A  81
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 ( 4.9A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.2A)
A79  A 800 (-3.8A)
A79  A 800 ( 3.9A)
A79  A 800 (-3.6A)
0.70A 4njtA-1hvcA:
13.7
4njtA-1hvcA:
43.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
ILE A  50
PRO A  81
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 ( 4.7A)
A79  A 800 ( 4.3A)
A79  A 800 ( 3.4A)
A79  A 800 ( 4.0A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.8A)
0.64A 4njtA-1hvcA:
13.7
4njtA-1hvcA:
43.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 LEU A  23
ASP A  25
ALA A  28
GLY A  48
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-3.6A)
A79  A 800 (-3.6A)
0.88A 4njtA-1hvcA:
13.7
4njtA-1hvcA:
43.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-4.1A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.8A)
1.05A 4njtA-1hvcA:
13.7
4njtA-1hvcA:
43.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 ( 3.9A)
A79  A 800 (-3.6A)
0.54A 4njtA-1hvcA:
13.7
4njtA-1hvcA:
43.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 ( 4.3A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.8A)
0.44A 4njtA-1hvcA:
13.7
4njtA-1hvcA:
43.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  30
VAL A  32
ILE A  47
GLY A  51
PRO A  81
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 ( 4.9A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.2A)
None
A79  A 800 ( 3.9A)
A79  A 800 (-3.6A)
1.20A 4njtA-1hvcA:
13.7
4njtA-1hvcA:
43.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
None
0.75A 4njtA-1q9pA:
10.1
4njtA-1q9pA:
84.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rvv RIBOFLAVIN SYNTHASE

(Bacillus
subtilis)
no annotation 5 ASP A  44
VAL A  43
ILE A  48
GLY A  16
ILE A  75
None
1.00A 4njtA-1rvvA:
undetectable
4njtA-1rvvA:
24.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ALA A  28
ASP A  30
ILE A  50
PRO A  81
ILE A  84
None
0.69A 4njtA-1sivA:
18.5
4njtA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
None
0.97A 4njtA-1sivA:
18.5
4njtA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.32A 4njtA-1sivA:
18.5
4njtA-1sivA:
48.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u89 TALIN 1

(Mus musculus)
no annotation 5 LEU A 806
ASP A 835
ILE A 862
THR A 809
ILE A 805
None
0.98A 4njtA-1u89A:
undetectable
4njtA-1u89A:
18.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v5f PYRUVATE OXIDASE

(Aerococcus
viridans)
PF00205
(TPP_enzyme_M)
PF02775
(TPP_enzyme_C)
PF02776
(TPP_enzyme_N)
5 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.92A 4njtA-1v5fA:
undetectable
4njtA-1v5fA:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2c7l PHYCOERYTHROCYANIN
BETA CHAIN


(Mastigocladus
laminosus)
PF00502
(Phycobilisome)
5 LEU B  44
ALA B 137
GLY B 130
ILE B 131
ILE B  51
None
0.99A 4njtA-2c7lB:
undetectable
4njtA-2c7lB:
18.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cl2 PUTATIVE
LAMINARINASE


(Phanerochaete
chrysosporium)
no annotation 5 LEU A  52
VAL A  89
ILE A 119
ILE A 248
ILE A 291
None
0.89A 4njtA-2cl2A:
undetectable
4njtA-2cl2A:
15.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
0.95A 4njtA-2fmbA:
15.0
4njtA-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
8 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
ILE A  89
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 (-4.2A)
0.42A 4njtA-2fmbA:
15.0
4njtA-2fmbA:
33.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ki7 RIBONUCLEASE P
PROTEIN COMPONENT 1


(Pyrococcus
furiosus)
PF01868
(UPF0086)
5 ASP A  72
VAL A  70
GLY A 110
ILE A  95
ILE A  80
None
0.91A 4njtA-2ki7A:
undetectable
4njtA-2ki7A:
22.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p3e DIAMINOPIMELATE
DECARBOXYLASE


(Aquifex
aeolicus)
PF00278
(Orn_DAP_Arg_deC)
PF02784
(Orn_Arg_deC_N)
5 ALA A 355
VAL A 371
GLY A 345
ILE A 308
ILE A 328
None
0.80A 4njtA-2p3eA:
undetectable
4njtA-2p3eA:
11.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pnm PROTEASE VP4

(Infectious
pancreatic
necrosis virus)
PF01768
(Birna_VP4)
5 LEU A 560
ALA A 674
ILE A 668
GLY A 687
ILE A 686
None
0.99A 4njtA-2pnmA:
undetectable
4njtA-2pnmA:
24.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q0l THIOREDOXIN
REDUCTASE


(Helicobacter
pylori)
PF07992
(Pyr_redox_2)
5 ALA A   5
VAL A  84
ILE A 108
GLY A   8
ILE A  93
None
None
None
FAD  A 400 (-3.2A)
None
0.93A 4njtA-2q0lA:
undetectable
4njtA-2q0lA:
15.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 (-4.2A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.78A 4njtA-2rkfA:
20.5
4njtA-2rkfA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.61A 4njtA-2rkfA:
20.5
4njtA-2rkfA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.52A 4njtA-2rkfA:
20.5
4njtA-2rkfA:
80.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wqd PHOSPHOENOLPYRUVATE-
PROTEIN
PHOSPHOTRANSFERASE


(Staphylococcus
aureus)
PF00391
(PEP-utilizers)
PF02896
(PEP-utilizers_C)
PF05524
(PEP-utilisers_N)
6 ASP A 228
VAL A 229
ILE A 204
GLY A 206
ILE A 185
ILE A   5
None
1.42A 4njtA-2wqdA:
undetectable
4njtA-2wqdA:
9.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z87 CHONDROITIN SYNTHASE

(Escherichia
coli)
PF00535
(Glycos_transf_2)
5 LEU A 238
ASP A 187
VAL A 185
ILE A 167
ILE A 156
None
1.00A 4njtA-2z87A:
undetectable
4njtA-2z87A:
10.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3all 2-METHYL-3-HYDROXYPY
RIDINE-5-CARBOXYLIC
ACID OXYGENASE


(Mesorhizobium
japonicum)
PF01494
(FAD_binding_3)
5 LEU A  30
ASP A 123
VAL A 122
ILE A 124
GLY A  19
None
None
None
None
FAD  A 380 ( 4.4A)
0.90A 4njtA-3allA:
undetectable
4njtA-3allA:
14.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dc8 DIHYDROPYRIMIDINASE

(Sinorhizobium
meliloti)
PF01979
(Amidohydro_1)
5 LEU A  41
VAL A  21
ILE A 382
THR A   3
ILE A   5
None
0.95A 4njtA-3dc8A:
undetectable
4njtA-3dc8A:
10.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3e4e CYTOCHROME P450 2E1

(Homo sapiens)
PF00067
(p450)
5 ALA A 438
GLY A 300
ILE A 180
THR A 292
ILE A 114
HEM  A 500 (-3.8A)
HEM  A 500 (-3.4A)
None
None
HEM  A 500 (-4.0A)
0.97A 4njtA-3e4eA:
undetectable
4njtA-3e4eA:
14.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fkj PUTATIVE
PHOSPHOSUGAR
ISOMERASES


(Salmonella
enterica)
PF01380
(SIS)
5 ALA A  99
ILE A  75
GLY A 102
ILE A 118
ILE A  15
None
0.75A 4njtA-3fkjA:
undetectable
4njtA-3fkjA:
11.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hhe RIBOSE-5-PHOSPHATE
ISOMERASE A


(Bartonella
henselae)
PF06026
(Rib_5-P_isom_A)
5 LEU A 219
ALA A 169
GLY A 162
ILE A 163
ILE A 222
None
0.96A 4njtA-3hheA:
undetectable
4njtA-3hheA:
17.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i1i HOMOSERINE
O-ACETYLTRANSFERASE


(Bacillus
anthracis)
PF00561
(Abhydrolase_1)
5 ALA A  54
VAL A  85
GLY A  70
ILE A 355
ILE A  44
None
0.90A 4njtA-3i1iA:
undetectable
4njtA-3i1iA:
12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3k6r PUTATIVE TRANSFERASE
PH0793


(Pyrococcus
horikoshii)
PF02475
(Met_10)
6 LEU A 197
ASP A 131
ALA A 153
ILE A 168
ILE A 136
PRO A 142
None
1.41A 4njtA-3k6rA:
undetectable
4njtA-3k6rA:
17.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3muu STRUCTURAL
POLYPROTEIN


(Sindbis virus)
PF00943
(Alpha_E2_glycop)
PF01589
(Alpha_E1_glycop)
5 LEU A 101
ASP A  36
VAL A  34
THR A  47
ILE A  45
None
0.91A 4njtA-3muuA:
undetectable
4njtA-3muuA:
8.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mwe ATP-CITRATE SYNTHASE

(Homo sapiens)
PF16114
(Citrate_bind)
5 LEU A 217
VAL A 121
ILE A 185
GLY A 187
ILE A 202
None
0.98A 4njtA-3mweA:
undetectable
4njtA-3mweA:
12.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
VAL A  32
GLY A  48
PRO A  81
ILE A  84
None
0.95A 4njtA-3mwsA:
19.8
4njtA-3mwsA:
70.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.45A 4njtA-3mwsA:
19.8
4njtA-3mwsA:
70.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nwg MICROCOMPARTMENTS
PROTEIN


(Desulfitobacterium
hafniense)
PF00936
(BMC)
5 LEU A  30
VAL A  52
ILE A  72
ILE A 104
ILE A  45
None
0.96A 4njtA-3nwgA:
undetectable
4njtA-3nwgA:
19.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3p0s CAPSID PROTEIN VP

(Lepidopteran
iteradensovirus
1)
PF01057
(Parvo_NS1)
5 VAL A 135
ILE A 367
GLY A 101
THR A 390
ILE A 388
None
0.93A 4njtA-3p0sA:
undetectable
4njtA-3p0sA:
11.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3p4g ANTIFREEZE PROTEIN

(Marinomonas
primoryensis)
no annotation 5 LEU A 162
ALA A 136
ASP A 122
VAL A 124
ILE A 143
None
CA  A 406 (-4.5A)
CA  A 404 ( 2.4A)
None
None
0.96A 4njtA-3p4gA:
undetectable
4njtA-3p4gA:
16.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pmo UDP-3-O-[3-HYDROXYMY
RISTOYL] GLUCOSAMINE
N-ACYLTRANSFERASE


(Pseudomonas
aeruginosa)
PF00132
(Hexapep)
PF04613
(LpxD)
5 ALA A 119
VAL A 115
ILE A 103
GLY A 122
ILE A 133
None
0.89A 4njtA-3pmoA:
undetectable
4njtA-3pmoA:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pz2 GERANYLGERANYL
TRANSFERASE TYPE-2
SUBUNIT BETA


(Rattus
norvegicus)
PF00432
(Prenyltrans)
5 LEU B 298
VAL B  56
ILE B  27
GLY B 276
ILE B 295
None
0.94A 4njtA-3pz2B:
undetectable
4njtA-3pz2B:
15.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qkc GERANYL DIPHOSPHATE
SYNTHASE SMALL
SUBUNIT


(Antirrhinum
majus)
no annotation 5 LEU B 183
VAL B 154
GLY B 112
ILE B 115
ILE B 153
None
0.98A 4njtA-3qkcB:
undetectable
4njtA-3qkcB:
15.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slz GAG-PRO-POL
POLYPROTEIN


(Murine leukemia
virus)
PF00077
(RVP)
5 LEU A  30
ASP A  32
ALA A  35
VAL A  39
GLY A  56
None
3TL  A 126 (-2.4A)
3TL  A 126 ( 4.0A)
None
3TL  A 126 (-3.4A)
0.34A 4njtA-3slzA:
11.3
4njtA-3slzA:
25.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slz GAG-PRO-POL
POLYPROTEIN


(Murine leukemia
virus)
PF00077
(RVP)
5 LEU A  30
ASP A  32
ALA A  35
VAL A  39
PRO A  89
None
3TL  A 126 (-2.4A)
3TL  A 126 ( 4.0A)
None
3TL  A 126 (-4.0A)
0.67A 4njtA-3slzA:
11.3
4njtA-3slzA:
25.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
SO4  A 101 (-4.2A)
017  A 201 (-2.6A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
None
0.70A 4njtA-3t3cA:
18.4
4njtA-3t3cA:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
SO4  A 101 (-4.2A)
017  A 201 (-2.6A)
017  A 201 (-3.5A)
None
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
None
0.87A 4njtA-3t3cA:
18.4
4njtA-3t3cA:
74.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tsn 4-HYDROXYTHREONINE-4
-PHOSPHATE
DEHYDROGENASE


(Campylobacter
jejuni)
PF04166
(PdxA)
5 ALA A  44
ILE A   8
GLY A  15
ILE A  14
ILE A  96
None
0.99A 4njtA-3tsnA:
undetectable
4njtA-3tsnA:
16.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-4.6A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
017  A 201 (-4.1A)
017  A 201 (-4.7A)
0.59A 4njtA-3ttpA:
19.7
4njtA-3ttpA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  30
ILE A  47
PRO A  81
None
017  A 202 ( 2.5A)
017  A 201 (-3.4A)
017  A 201 ( 4.0A)
017  A 202 (-3.6A)
017  A 202 (-4.0A)
0.62A 4njtA-3u7sA:
19.9
4njtA-3u7sA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
ALA A  28
ILE A  47
GLY A  49
ILE A  50
PRO A  81
None
017  A 202 ( 2.5A)
017  A 201 (-3.4A)
017  A 202 (-3.6A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
017  A 202 (-4.0A)
0.57A 4njtA-3u7sA:
19.9
4njtA-3u7sA:
78.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ao7 ESTERASE

(unidentified)
PF12146
(Hydrolase_4)
5 ALA A 125
VAL A  31
ILE A 119
PRO A  82
ILE A  79
None
0.97A 4njtA-4ao7A:
undetectable
4njtA-4ao7A:
17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bed HEMOCYANIN KLH1

(Megathura
crenulata)
PF00264
(Tyrosinase)
PF14830
(Haemocyan_bet_s)
5 ALA B2984
ASP B3152
ILE B2979
ILE B3104
ILE B2942
None
0.95A 4njtA-4bedB:
undetectable
4njtA-4bedB:
4.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4c3y 3-KETOSTEROID
DEHYDROGENASE


(Rhodococcus
erythropolis)
PF00890
(FAD_binding_2)
5 LEU A 103
ALA A 180
ILE A 174
PRO A 134
ILE A 109
None
0.93A 4njtA-4c3yA:
undetectable
4njtA-4c3yA:
11.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fln PROTEASE DO-LIKE 2,
CHLOROPLASTIC


(Arabidopsis
thaliana)
PF13180
(PDZ_2)
PF13365
(Trypsin_2)
5 ASP A 218
VAL A 220
ILE A 280
ILE A 299
ILE A 259
None
0.96A 4njtA-4flnA:
undetectable
4njtA-4flnA:
12.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fmg VP1

(Human
polyomavirus 5)
PF00718
(Polyoma_coat)
5 VAL A 311
ILE A 168
GLY A 170
THR A  53
ILE A  55
None
0.91A 4njtA-4fmgA:
undetectable
4njtA-4fmgA:
15.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fys AMINOPEPTIDASE N

(Homo sapiens)
PF01433
(Peptidase_M1)
PF11838
(ERAP1_C)
6 LEU A 390
ALA A 317
VAL A 382
GLY A 345
ILE A 344
ILE A 386
None
1.40A 4njtA-4fysA:
undetectable
4njtA-4fysA:
8.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4i0w PROTEASE CSPB

(Clostridium
perfringens)
PF00082
(Peptidase_S8)
5 LEU B 318
VAL B 361
ILE B 343
ILE B 333
ILE B 377
None
EDO  B 606 (-4.6A)
None
None
None
0.97A 4njtA-4i0wB:
undetectable
4njtA-4i0wB:
14.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4inj LMO1638 PROTEIN

(Listeria
monocytogenes)
PF02016
(Peptidase_S66)
5 LEU A 162
ALA A 309
GLY A 306
ILE A 305
ILE A 321
None
0.82A 4njtA-4injA:
undetectable
4njtA-4injA:
16.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4iu4 ARGINASE

(Leishmania
mexicana)
PF00491
(Arginase)
5 LEU A 263
ASP A 302
VAL A 252
THR A 246
ILE A 247
None
0.95A 4njtA-4iu4A:
undetectable
4njtA-4iu4A:
17.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4iv9 TRYPTOPHAN
2-MONOOXYGENASE


(Pseudomonas
savastanoi)
PF01593
(Amino_oxidase)
5 LEU A 508
VAL A 325
ILE A 312
GLY A 301
ILE A 337
None
0.99A 4njtA-4iv9A:
undetectable
4njtA-4iv9A:
11.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lur INTERPHOTORECEPTOR
RETINOID-BINDING
PROTEIN(IRBP)


(Danio rerio)
PF03572
(Peptidase_S41)
PF11918
(Peptidase_S41_N)
5 ILE A 115
GLY A 155
ILE A 156
THR A 148
ILE A 111
None
0.93A 4njtA-4lurA:
undetectable
4njtA-4lurA:
15.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
GLY A  48
PRO A  81
THR A  82
ILE A  84
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
RIT  A 500 (-4.8A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.5A)
RIT  A 500 (-4.3A)
0.79A 4njtA-4njvA:
21.7
4njtA-4njvA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
THR A  82
ILE A  84
None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
RIT  A 500 (-4.8A)
None
RIT  A 500 ( 4.5A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.5A)
RIT  A 500 (-4.3A)
0.50A 4njtA-4njvA:
21.7
4njtA-4njvA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p8r GLYCERALDEHYDE
3-PHOSPHATE
DEHYDROGENASE,
CYTOSOLIC


(Trypanosoma
brucei)
PF00044
(Gp_dh_N)
PF02800
(Gp_dh_C)
5 ALA A  21
VAL A   5
ILE A 326
ILE A  13
ILE A  29
MG  A 401 (-4.5A)
None
None
NAD  A 400 (-4.3A)
None
0.90A 4njtA-4p8rA:
undetectable
4njtA-4p8rA:
16.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4r37 PUTATIVE
ACYL-[ACYL-CARRIER-P
ROTEIN]--UDP-N-ACETY
LGLUCOSAMINE
O-ACYLTRANSFERASE


(Bacteroides
fragilis)
PF00132
(Hexapep)
PF13720
(Acetyltransf_11)
5 LEU A 110
ALA A  60
ILE A  44
GLY A  63
ILE A  86
None
0.98A 4njtA-4r37A:
undetectable
4njtA-4r37A:
22.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ryf ATP-DEPENDENT CLP
PROTEASE PROTEOLYTIC
SUBUNIT


(Listeria
monocytogenes)
PF00574
(CLP_protease)
5 ALA H 155
VAL H 164
GLY H 184
THR H 169
ILE H 165
None
0.97A 4njtA-4ryfH:
undetectable
4njtA-4ryfH:
17.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4u0g ATP-DEPENDENT CLP
PROTEASE PROTEOLYTIC
SUBUNIT 2


(Mycobacterium
tuberculosis)
PF00574
(CLP_protease)
5 ALA A 169
VAL A 178
GLY A 198
THR A 183
ILE A 179
None
0.99A 4njtA-4u0gA:
undetectable
4njtA-4u0gA:
17.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4x9n L-ALPHA-GLYCEROPHOSP
HATE OXIDASE


(Mycoplasma
pneumoniae)
PF01266
(DAO)
5 LEU A 343
VAL A  13
GLY A  69
THR A  18
ILE A  14
None
FAD  A 401 (-4.4A)
None
None
FAD  A 401 (-4.0A)
0.99A 4njtA-4x9nA:
undetectable
4njtA-4x9nA:
15.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
6 LEU A  30
ASP A  32
ALA A  35
VAL A  39
GLY A  58
ILE A 100
None
4B1  A 201 (-2.9A)
4B1  A 201 (-3.6A)
None
4B1  A 201 (-3.4A)
4B1  A 201 (-4.8A)
0.38A 4njtA-4ydfA:
12.9
4njtA-4ydfA:
33.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ywl CELL DIVISION
CONTROL PROTEIN 21


(Pyrococcus
furiosus)
PF14551
(MCM_N)
PF17207
(MCM_OB)
5 VAL A 221
ILE A 187
GLY A 205
ILE A 206
ILE A 249
None
0.98A 4njtA-4ywlA:
undetectable
4njtA-4ywlA:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ztk CELL DIVISION
PROTEIN
FTSI/PENICILLIN
BINDING PROTEIN 2


(Legionella
pneumophila)
PF00905
(Transpeptidase)
5 LEU A 512
ALA A 367
GLY A 364
ILE A 600
ILE A 509
None
1.00A 4njtA-4ztkA:
undetectable
4njtA-4ztkA:
15.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cw5 BRCA1/BRCA2-CONTAINI
NG COMPLEX SUBUNIT 3


(Camponotus
floridanus)
PF01398
(JAB)
5 LEU A  79
VAL A  89
GLY A  33
ILE A  51
ILE A  36
None
0.99A 4njtA-5cw5A:
undetectable
4njtA-5cw5A:
16.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5eaw DNA REPLICATION
ATP-DEPENDENT
HELICASE/NUCLEASE
DNA2


(Mus musculus)
PF08696
(Dna2)
PF13086
(AAA_11)
PF13087
(AAA_12)
5 VAL A 786
ILE A 659
ILE A 665
THR A 645
ILE A 647
None
0.96A 4njtA-5eawA:
undetectable
4njtA-5eawA:
7.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ilb PROTEASE DO-LIKE 2,
CHLOROPLASTIC,PROTEA
SE DO-LIKE 9


(Arabidopsis
thaliana)
PF13180
(PDZ_2)
PF13365
(Trypsin_2)
5 ASP A 218
VAL A 220
ILE A 280
ILE A 299
ILE A 259
None
0.96A 4njtA-5ilbA:
undetectable
4njtA-5ilbA:
11.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lnb UBIQUITIN-LIKE-SPECI
FIC PROTEASE 2


(Saccharomyces
cerevisiae)
PF02902
(Peptidase_C48)
5 LEU B 166
VAL B 118
ILE B  66
THR B 133
ILE B 131
None
0.93A 4njtA-5lnbB:
undetectable
4njtA-5lnbB:
15.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ms7 LEGIONELLA
PNEUMOPHILA EFFECTOR
PROTEIN RAVZ


(Legionella
pneumophila)
no annotation 5 LEU A 413
VAL A 422
ILE A 382
GLY A 371
ILE A 370
None
0.95A 4njtA-5ms7A:
undetectable
4njtA-5ms7A:
16.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5n4l CERULOPLASMIN

(Rattus
norvegicus)
no annotation 5 ALA A 102
VAL A  88
ILE A  78
GLY A 175
ILE A 174
None
0.97A 4njtA-5n4lA:
undetectable
4njtA-5n4lA:
23.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
PRO A  81
ILE A  84
None
0.65A 4njtA-5t2zA:
19.9
4njtA-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.48A 4njtA-5t2zA:
19.9
4njtA-5t2zA:
85.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tc3 INOSINE-5'-MONOPHOSP
HATE DEHYDROGENASE


(Eremothecium
gossypii)
PF00478
(IMPDH)
PF00571
(CBS)
5 LEU A 248
VAL A  72
ILE A 365
GLY A 323
ILE A  94
None
0.99A 4njtA-5tc3A:
undetectable
4njtA-5tc3A:
11.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tc4 BIFUNCTIONAL
METHYLENETETRAHYDROF
OLATE
DEHYDROGENASE/CYCLOH
YDROLASE,
MITOCHONDRIAL


(Homo sapiens)
PF00763
(THF_DHG_CYH)
PF02882
(THF_DHG_CYH_C)
5 ALA A 269
VAL A 298
ILE A 305
ILE A 251
ILE A 265
None
0.86A 4njtA-5tc4A:
undetectable
4njtA-5tc4A:
15.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5x8o INOSINE-5'-MONOPHOSP
HATE DEHYDROGENASE


(Trypanosoma
brucei)
no annotation 5 LEU A 230
VAL A  50
ILE A 349
GLY A 307
ILE A  72
None
0.99A 4njtA-5x8oA:
undetectable
4njtA-5x8oA:
17.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6b3e CYCLIN-DEPENDENT
KINASE 12


(Homo sapiens)
no annotation 5 ALA A 993
ASP A 995
GLY A 923
ILE A 925
ILE A 989
None
0.95A 4njtA-6b3eA:
undetectable
4njtA-6b3eA:
19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6brs PUTATIVE ZINC
PROTEASE


(Pectobacterium
atrosepticum)
no annotation 6 LEU A 138
ALA A 236
GLY A 229
ILE A 228
PRO A 127
THR A 137
None
1.39A 4njtA-6brsA:
undetectable
4njtA-6brsA:
24.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cfd ATP-DEPENDENT CLP
PROTEASE PROTEOLYTIC
SUBUNIT


(Enterococcus
faecium)
no annotation 5 ALA A 155
VAL A 164
GLY A 184
THR A 169
ILE A 165
None
0.96A 4njtA-6cfdA:
undetectable
4njtA-6cfdA:
17.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ei3 PROTON-DEPENDENT
OLIGOPEPTIDE
TRANSPORTER FAMILY
PROTEIN


(Xanthomonas
campestris)
no annotation 5 LEU A 173
ALA A 186
GLY A 191
ILE A 192
ILE A 174
None
None
None
78M  A 603 (-4.3A)
None
0.95A 4njtA-6ei3A:
undetectable
4njtA-6ei3A:
11.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
5 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
0.97A 4njtA-6upjA:
17.9
4njtA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
0.77A 4njtA-6upjA:
17.9
4njtA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
0.79A 4njtA-6upjA:
17.9
4njtA-6upjA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
6 LEU A  23
ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
NIU  A 100 (-2.8A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
0.92A 4njtA-6upjA:
17.9
4njtA-6upjA:
47.47